Vulvar and vaginal intraepithelial neoplasia (VIN/VAIN) 3 [Vulväre und vaginale intraepitheliale neoplasie (VIN/VAIN) 3]

被引:0
|
作者
Jentschke M. [1 ]
Soergel P. [1 ]
Hillemanns P. [1 ]
机构
[1] Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1
来源
Der Gynäkologe | 2012年 / 45卷 / 4期
关键词
Human papillomavirus; Imiquimod; Intraepithelial neoplasias; Photodynamic therapy; Vaccination;
D O I
10.1007/s00129-011-2897-1
中图分类号
学科分类号
摘要
VIN 3 and VAIN 3 are associated with HPV infection of the lower genital tract. Compared to CIN they are much less frequent, but there has been an increase in the incidence of VIN over the last decades. VIN often causes pain and pruritus, while VAIN is asymptomatic in most cases and is diagnosed after abnormal Pap smear. VIN and VAIN are treated similarly. Single lesions can be excised. (Hemi-) vulvectomy or partial vaginectomy is necessary in cases of large or multifocal lesions. Laser vaporization is another effective treatment method. The immune modulator imiquimod is the most popular medical treatment. Recurrence of VIN and VAIN after treatment is not uncommon. Progression to invasive cancer happens in 5-10%. New methods like photodynamic therapy can help to improve the treatment of VIN and VAIN in the future. © Springer-Verlag 2012.
引用
收藏
页码:304 / 308
页数:4
相关论文
共 34 条
  • [31] Expression of vascular endothelial growth factors VEGF-C and -D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer
    Jach, Robert
    Dyduch, Grzegorz
    Radon-Pokracka, Malgorzata
    Przybylska, Paulina
    Mika, Marcin
    Dulinska-Litewka, Joanna
    Zajac, Krzysztof
    Huras, Hubert
    Streb, Joanna
    Stangel-Wojcikiewicz, Klaudia
    Dziadek, Olivia
    Galarowicz, Bartlomiej
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (04) : 530 - 539
  • [32] Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial
    Tristram, Amanda
    Hurt, Christopher N.
    Madden, Tracie
    Powell, Ned
    Man, Stephen
    Hibbitts, Sam
    Dutton, Peter
    Jones, Sadie
    Nordin, Andrew J.
    Naik, Raj
    Fiander, Alison
    Griffiths, Gareth
    LANCET ONCOLOGY, 2014, 15 (12): : 1361 - 1368
  • [33] LONG TERM RESULTS FROM RT3VIN: A MULTI-CENTRE, RANDOMISED, PHASE II TRIAL OF CIDOFOVIR OR IMIQUIMOD TREATMENT FOR VULVAL INTRAEPITHELIAL NEOPLASIA
    Jones, S.
    Hurt, C.
    Madden, T.
    Fiander, A.
    Nordin, A.
    Naik, R.
    Powell, N.
    Tristram, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 960 - 960
  • [34] High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999
    Sykes, P
    Smith, N
    McCormick, P
    Frizelle, FA
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2002, 42 (01): : 69 - 74